Clinical Trial Detail

NCT ID NCT02332889
Title Phase I/II Decitabine/Vaccine Therapy in Relapsed/Refractory Pediatric High Grade Gliomas/Medulloblastomas/CNS PNETs
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Louisville
Indications

malignant glioma

medulloblastoma

Therapies

Decitabine

Poly ICLC

Age Groups: child

No variant requirements are available.